Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
GALECTIN (NQ: GALT)
3.980 USD  -0.180 (-4.33%)
Official Closing Price  /  Updated: 3:59 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News
Press releases about GALECTIN
 
Tumor Immunotherapy Efficacy Increased in Both Breast and Prostate Cancer Preclinical Models with Addition of Galectin Inhibitor
June 12, 2013
-- Galectin Therapeutics and Earle A. Chiles Research Institute - Read More
from PR Newswire
Galectin Therapeutics to Hold Conference Call to Provide Update Following Company's Annual Meeting of Shareholders -- New Phone Number for Audio Portion of Presentation
May 23, 2013
from PR Newswire
Galectin Therapeutics to Hold Conference Call to Provide Update Following Company's Annual Meeting of Shareholders
May 15, 2013
from PR Newswire
Galectin Therapeutics Reports First Quarter 2013 Financial Results
May 10, 2013
from PR Newswire
Galectin Inhibitors Reverse Liver Cirrhosis in Preclinical Studies
April 29, 2013
- Galectin Therapeutics and Icahn School of Medicine at Mount Sinai Data Presented at the International Liver Congress 2013 - Read More
from PR Newswire
RedChip TV Announces Guest Lineup for This Week's "RedChip Money Report"
April 19, 2013
April 20 Show to Feature Interviews With Three Emerging Growth Companies Read More
from GlobeNewswire News Releases
Galectin Therapeutics to Present New Data on the Treatment of Liver Fibrosis and Cirrhosis
April 17, 2013
-- Abstract Accepted for Presentation at the International Liver Congress 2013 -- Read More
from PR Newswire
RedChip TV Announces Guest Lineup for This Week's "RedChip Money Report"
April 12, 2013
April 13 Show to Feature Interviews With Three Emerging Growth Companies Read More
from GlobeNewswire News Releases
Clinical Trial Sites for First Human Clinical Trial for Treatment of Fatty Liver Disease with Advanced Fibrosis Announced by Galectin Therapeutics
April 09, 2013
from PR Newswire
Galectin Therapeutics: Turning Atlanta into America's Next Silicon Valley
April 04, 2013
from PR Newswire
Galectin Therapeutics: Turning Atlanta into America's Next Silicon Valley
April 04, 2013
Former Silicon Valley Leaders Say Atlanta Emerging as "Silicon Valley for Biotech" and Curing Big Diseases Read More
from PR Newswire
Galectin Therapeutics Reports Full Year and Fourth Quarter 2012 Financial Results
March 29, 2013
from PR Newswire
Galectin Therapeutics Inc. Receives OK from FDA to Proceed with First Human Clinical Trial for Treatment of Fatty Liver Disease with Advanced Fibrosis
March 05, 2013
from PR Newswire
RedChip TV Announces Guest Lineup for This Week's "Money Report" on Fox Business News
February 20, 2013
February 23, 2013 Show to Feature Interviews With Three Emerging Growth Companies Read More
from GlobeNewswire News Releases
Galectin Therapeutics Announces Discovery Program for New Anti-Galectin Drugs in Collaboration with the University of Georgia
February 19, 2013
from Business Wire News Releases
"The RedChip Money Report" Airing Nationally on Fox Business News
February 08, 2013
February 9, 2013 Show to Feature Four Emerging Growth Companies Read More
from GlobeNewswire News Releases
Galectin Therapeutics Executive Chairman, James Czirr to Appear on “The RedChip Money Report” on FOX Business News
February 07, 2013
from Business Wire News Releases
Galectin Therapeutics Inc. Announces Submission of an Investigational New Drug (IND) Application for the Treatment of Fatty Liver Disease
January 31, 2013
from Business Wire News Releases
"The RedChip Money Report" Begins Airing Nationally on Fox Business News
January 29, 2013
Show to Air Saturdays at 2 p.m. Eastern Beginning February 2, 2013 Read More
from GlobeNewswire News Releases
Galectin Therapeutics Inc. Announces Publication of Galectin Symposium Proceedings by the American Chemical Society
January 28, 2013
from Business Wire News Releases
New Potential Therapy for Diabetic Kidney Disease: Galectin Therapeutics Announces Anti-Galectin Drug is Effective in Preclinical Studies
January 22, 2013
from Business Wire News Releases
The Real Story Behind NETE, BLRX, RSYS and GALT
January 16, 2013
from Marketwired News Releases
Galectin Therapeutics Appoints Industry Veteran Rex Horton as Executive Director of Regulatory Affairs and Quality Assurance
January 15, 2013
from Business Wire News Releases
Free Research Reports on ALXA, ANAD, GALT and MMR Issued by the Bedford Report
November 27, 2012
The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases
November 27, 2012
Five Star Equities Provides Stock Research on Cytokinetics and Galectin Therapeutics Read More
from Marketwired News Releases
Galectin Therapeutics Receives US Patent for Second Drug Class to Treat Chronic Liver Disease with Fibrosis (Scarring) and Cirrhosis
November 26, 2012
from Business Wire News Releases
Galectin Therapeutics Presents New Data on the Treatment of Fatty Liver Disease and Fibrosis at AASLD 2012
November 12, 2012
from Business Wire News Releases
Galectin Therapeutics Reports Third Quarter 2012 Financial Results
November 09, 2012
from Business Wire News Releases
RedChip Announces Third Episode of Its Financial Television Program
November 05, 2012
Episode 3 of "The RedChip Money Report" Features Interviews With Four Small-Cap Companies Read More
from GlobeNewswire News Releases
Galectin Therapeutics to Present New Data on the Treatment of Fatty Liver Disease and Fibrosis at AASLD 2012
October 26, 2012
from Business Wire News Releases
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here